This meta-analysis is reassuring regarding risk for malformations in children exposed prenatally to oxcarbazepine; however, we still need more data to fully assess reproductive safety.

The post Still Not Enough Data on the Reproductive Safety of Oxcarbazepine (Trileptal) appeared first on MGH Center for Women’s Mental Health.

Leave a Reply

Your email address will not be published. Required fields are marked *